Chronic intestinal pseudo-obstruction, usually abbreviated CIPO, is a rare condition in which the gut behaves as though it is physically blocked even though no actual blockage exists.1PubMed Central. Latest developments in chronic intestinal pseudo-obstruction The intestines simply fail to push food and waste forward the way they should. The result is severe, recurring episodes of bloating, pain, nausea, vomiting, and constipation that can look identical to a true mechanical obstruction on imaging and at the bedside. Because it mimics a surgical emergency without being one, CIPO is notoriously difficult to diagnose and even harder to manage over the long term.
What Goes Wrong Inside the Gut
In a healthy digestive tract, coordinated waves of muscle contraction move contents from the stomach through the small intestine and into the colon. CIPO disrupts that coordination. The problem can sit in any of three layers of the gut wall: the nerves that signal when and where to contract, the smooth muscle cells that carry out the contraction, or the specialized cells between the two (called interstitial cells of Cajal) that serve as pacemakers for the whole system.
Clinicians classify CIPO based on which layer is affected. In most patients the underlying problem is neuropathic, meaning the nerves themselves are damaged or dysfunctional. A smaller proportion have a myopathic form, where the muscle layer is the weak link. A third, less common category involves defects in the interstitial pacemaker cells.2PubMed. Chronic intestinal pseudo-obstruction Knowing which category a person falls into matters because it shapes treatment decisions, anticipated complications, and prognosis.
Causes and Risk Factors
CIPO is sometimes inherited, sometimes acquired, and sometimes appears without any identifiable trigger. In the genetic camp, the best-studied culprit is a gene called ACTG2, which encodes a protein critical to the contractile machinery of enteric smooth muscle. Mutations in ACTG2 have been linked to a spectrum of disease severity. At the extreme end sits megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS), a condition usually detected before birth through an abnormally enlarged bladder. Milder ACTG2 mutations can present later in life as chronic pseudo-obstruction with or without bladder involvement.3PLOS Genetics. Heterozygous De Novo and Inherited Mutations in the Smooth Muscle Actin (ACTG2) Gene Underlie Megacystis-Microcolon-Intestinal Hypoperistalsis Syndrome Some of these mutations arise spontaneously rather than being inherited from a parent, which explains why a child can have CIPO with no family history of the disease.
Other genetic causes exist, but they tend to involve additional organ systems rather than the gut alone. Mutations in mitochondrial DNA and certain recessive genes have been linked to CIPO as part of broader multi-system disorders.4PubMed Central. Diagnosis of Chronic Intestinal Pseudo-Obstruction & Megacystis by Sequencing the ACTG2 Gene
On the acquired side, several systemic diseases can cause secondary CIPO by damaging the gut’s nerves or muscle. Systemic sclerosis (a connective tissue disease that causes skin and organ fibrosis) tends to produce a myopathic pattern, while paraneoplastic syndromes, in which a cancer triggers the immune system to attack the patient’s own nerves, tend to produce a neuropathic pattern.5PubMed Central. Comparing Clinical, Imaging, and Physiological Correlates of Intestinal Pseudo-Obstruction: Systemic Sclerosis vs Amyloidosis and Paraneoplastic Syndrome Amyloidosis, in which abnormal proteins deposit in tissues, is another recognized cause. Diabetes, hypothyroidism, and certain medications, particularly opioids and some psychiatric drugs, can also impair gut motility severely enough to mimic pseudo-obstruction, though these are usually distinguished clinically from true CIPO.
When CIPO Starts in Childhood
CIPO is not exclusively an adult disease. A significant subset of cases begins in infancy or early childhood, and the presentation can look quite different from the adult version. The most dramatic pediatric form is MMIHS, which is often detected before birth. Ultrasound findings of an enlarged fetal bladder raise suspicion in roughly nine out of ten cases.6PubMed Central. Paediatric intestinal pseudo-obstruction: a scoping review Affected newborns typically have a tiny, unused colon (microcolon) alongside the bladder and intestinal problems.7Journal of Neurogastroenterology and Motility. ACTG2 Variants in Pediatric Chronic Intestinal Pseudo-obstruction With Megacystis
Not all pediatric CIPO is that severe. Some children develop symptoms months or years after birth, with chronic vomiting, progressive abdominal distension, and failure to thrive as the leading complaints. These children often undergo repeated imaging studies and exploratory surgeries before the diagnosis is made, partly because CIPO is rare enough that many pediatricians and surgeons see only one or two cases in a career.
How the Diagnosis Is Made
The challenge with CIPO is that it is a diagnosis of exclusion. The first job is ruling out a real mechanical obstruction, which typically means CT scans, barium studies, or both. Once no physical blockage is found, doctors look at the pattern and severity of symptoms, the degree of intestinal dilation on imaging, and functional testing to characterize how the gut is (or isn’t) moving.
Gastrointestinal manometry is the most informative functional test. A pressure-sensing catheter is placed inside the stomach, small intestine, or colon, and pressure patterns are recorded over several hours, often including a meal to see whether the gut responds with the normal postprandial burst of contractions. In children studied with colonic manometry, those with a myopathic form of CIPO showed no contractions at all, while those with a neuropathic form still had some contractile activity, just poorly coordinated.8PubMed. Colonic manometry in children with chronic intestinal pseudo-obstruction That distinction between “disordered contractions” and “no contractions” is one of the clearest ways to separate the neuropathic and myopathic subtypes.
When manometry alone is not enough, a full-thickness biopsy of the intestinal wall can reveal the underlying pathology directly. Unlike the superficial biopsies taken during a standard endoscopy, a full-thickness biopsy includes the muscle and nerve layers. Specialized staining techniques can then identify whether nerves, muscle fibers, or pacemaker cells are abnormal.9PubMed. Full-thickness biopsy findings in chronic intestinal pseudo-obstruction and enteric dysmotility This is an invasive step that usually requires surgery, so it tends to be reserved for cases where the information will genuinely change management.
Complications That Make CIPO Dangerous
CIPO is not just uncomfortable. Stagnant gut contents create a breeding ground for bacteria, leading to small intestinal bacterial overgrowth (SIBO). SIBO causes its own layer of bloating, diarrhea, and malabsorption, making an already bad nutritional situation worse. Bacterial overgrowth can also lead to translocation, where bacteria cross the gut wall into the bloodstream, causing sepsis. Medical treatment in CIPO is largely aimed at preventing exactly these two complications while trying to restore whatever forward motion the gut can still produce.10Wiley Online Library. Chronic intestinal pseudo-obstruction in children and adults: diagnosis and therapeutic options
Malnutrition is the other major threat. When the gut cannot move food through effectively, absorbing nutrients becomes unreliable. Many patients lose significant weight and develop deficiencies in vitamins, minerals, and protein before the diagnosis is even made. Over time, progressive malnutrition weakens muscles, impairs immune function, and degrades bone health, creating a cascade of problems well beyond the gut itself.
Medical Treatment
There is no drug that cures CIPO. Instead, the medical approach focuses on coaxing the gut into better function and managing symptoms when it doesn’t cooperate. Prokinetic agents, drugs that promote gut motility, are commonly tried. Erythromycin (an antibiotic that happens to stimulate gut contractions), octreotide (a synthetic hormone), and metoclopramide are all used, though response rates vary widely from patient to patient.
One drug that has attracted particular attention is pyridostigmine, a cholinesterase inhibitor originally used for myasthenia gravis. By preventing the breakdown of acetylcholine, a key chemical messenger in the gut’s nervous system, it effectively turns up the volume on the signals that tell the intestinal muscles to contract. Published studies consistently report improvement: reduced abdominal distension, less reliance on intravenous nutrition, and better tolerance of eating by mouth.11PubMed Central. Pyridostigmine in Pediatric Intestinal Pseudo-obstruction: Case Report of a 2-year Old Girl and Literature Review A systematic review of the available evidence confirmed that the drug appears beneficial with a low side-effect profile, though the authors cautioned that the existing studies are small.12PubMed. Pyridostigmine in chronic intestinal pseudo-obstruction – a systematic review The evidence is encouraging, but this is still an area where stronger trials are needed.
Cycling antibiotics to keep bacterial overgrowth in check is another mainstay. Because the same stagnant-gut environment that causes overgrowth persists after treatment, SIBO tends to recur, and patients often rotate through different antibiotics to reduce the risk of resistance.
Feeding and Nutritional Support
For many people with CIPO, eating normally is simply not an option. Some can tolerate small, frequent, low-fiber meals, especially liquids and soft foods that place less demand on the gut’s contractile machinery. But when oral intake is insufficient, enteral feeding through a tube placed into the stomach or small bowel may help. If even that fails, the only remaining option is parenteral nutrition (PN), where a concentrated nutrient solution is delivered directly into the bloodstream through a central venous catheter.
Home parenteral nutrition can be genuinely life-changing. In one study of ten patients disabled by CIPO, transitioning to home PN coupled with minimal oral intake effectively eliminated symptoms and reversed severe malnutrition: body weight, lean mass, and body fat all improved significantly.13PubMed. Successful management of chronic intestinal pseudo-obstruction with home parenteral nutrition The trade-off is that PN carries its own serious risks, including bloodstream infections from the central line and progressive liver damage from long-term intravenous feeding. Those complications can eventually become life-threatening themselves.
Surgical Options and Venting Procedures
Surgery in CIPO is generally aimed at managing complications rather than fixing the underlying motility disorder. One of the most useful interventions is a venting enterostomy or gastrostomy, a surgically created opening in the stomach or intestine that allows gas and fluid to escape, relieving the severe distension and pain that come with pseudo-obstructive episodes. Combined with parenteral nutrition, venting procedures have dramatically reduced the need for emergency hospitalizations. In one series of 22 patients (adults and children), admissions for obstruction dropped from about 1.2 per patient-year before treatment to 0.2 per patient-year afterward.14JAMA Surgery. Chronic Intestinal Pseudo-obstruction: Management With Total Parenteral Nutrition and a Venting Enterostomy A similar pediatric experience showed a roughly tenfold decrease in operations for obstruction after routine adoption of these techniques.15PubMed. Surgical management of chronic intestinal pseudo-obstruction in infancy and childhood
Some patients undergo resection of a severely dysfunctional segment, and in rare cases an ileostomy or colostomy may be created to divert contents. These procedures sometimes help, but because CIPO is frequently diffuse rather than limited to one region, removing a segment of bowel does not always solve the problem and can leave the patient with less absorptive surface to work with.
Intestinal Transplantation
When parenteral nutrition becomes unsustainable, either because of repeated line infections, loss of venous access, or progressive liver failure, intestinal transplantation enters the conversation. This is not a first-line treatment; it is a last resort for patients who have developed irreversible complications from PN. In a small series of adult CIPO patients who underwent isolated intestinal transplant, one-year patient survival was about 83% and graft survival about 67%.16PubMed. Intestinal transplantation for chronic intestinal pseudo-obstruction in adult patients Longer-term follow-up data suggest that outcomes in CIPO patients are comparable to those seen in patients transplanted for short bowel syndrome, which is encouraging given that transplantation in CIPO involves additional technical challenges related to the native stomach’s poor emptying.17PubMed. Isolated intestinal transplant for chronic intestinal pseudo-obstruction in adults: long-term outcome
The field of intestinal transplantation has improved substantially over the past two decades, but it remains a high-risk procedure with lifelong immunosuppression, chronic rejection concerns, and significant mortality. For the subset of CIPO patients who truly cannot survive on PN, it offers a path to resuming oral feeding and escaping the complications of intravenous nutrition.
Living With CIPO and the Case for Multidisciplinary Care
CIPO is not just a gut problem. Chronic pain, often severe, is a central feature of the disease, and it creates a difficult treatment paradox: opioids, the most commonly prescribed strong painkillers, further slow gut motility and can worsen the very symptoms they are meant to relieve. Managing pain in CIPO typically requires a specialist comfortable with non-opioid strategies, nerve blocks, and psychological approaches to chronic pain.
Clinical guidelines recommend a multidisciplinary team that includes a gastroenterologist, surgeon, chronic pain specialist, clinical nutritionist, and psychologist.18PubMed Central. Chronic Intestinal Pseudo-obstruction That sounds like a lot of doctors, but the reasoning is practical. Nutritional status, pain management, surgical timing, and mental health are all deeply intertwined in this disease, and decisions in one domain regularly affect outcomes in another. A nutritionist adjusting a feeding regimen needs to know what the gastroenterologist is doing about bacterial overgrowth. A surgeon planning a venting procedure needs to know what the pain team has tried. Without coordination, care fragments quickly.
The psychological burden deserves particular emphasis. People with CIPO frequently describe social isolation, depression, and anxiety. Eating is a social activity, and when meals cause hours of pain and distension, many patients withdraw from the dining table and, by extension, from much of everyday social life. Parenteral nutrition tethers a person to an IV pole for hours each day, often overnight. For children, this means missed school, limited physical activity, and the feeling of being different from peers. For adults, it can mean lost careers and strained relationships. Mental health support is not an optional add-on in this disease; it is a core part of treatment.
Gut Microbiome Research
One emerging area of investigation is the gut microbiome. Patients with CIPO appear to harbor a distinctly different bacterial community compared to healthy individuals. Recent research found that the microbial communities in CIPO patients were enriched in genes related to oxidative stress and showed a bloom of bacteria from the Escherichia-Shigella family, along with increased lipopolysaccharide biosynthesis pathways, which are associated with inflammation. Stool analyses confirmed higher levels of certain fatty acids in CIPO patients compared to healthy controls.19PubMed Central. The role of gut microbiota in chronic intestinal pseudo-obstruction: exploring fecal microbiota transplantation as a treatment option
Whether these microbial differences are a cause of symptoms, a consequence of stagnant gut contents, or both is still unclear. Fecal microbiota transplantation (FMT), which involves introducing a healthy donor’s stool into a patient’s gut to reset the microbial community, is being explored as a potential treatment. The rationale is plausible: if a dysfunctional microbiome is amplifying inflammation and worsening motility, restoring a healthier bacterial population might offer some relief. But the evidence is preliminary, and FMT is not yet a standard treatment for CIPO.
Gastric Electrical Stimulation
For patients whose most debilitating symptom is intractable vomiting, gastric electrical stimulation (GES) is a technology worth knowing about. A small device, similar in concept to a cardiac pacemaker, is surgically implanted and delivers mild electrical pulses to the stomach wall. In CIPO patients with medically uncontrollable vomiting, GES reduced the weekly frequency of vomiting from a mean of 24 episodes to about 7 at one year of follow-up, a reduction of roughly 50 to 90% at the last visit.20Wiley Online Library / Neurogastroenterology & Motility. Gastric electrical stimulation for intractable vomiting in patients with chronic intestinal pseudoobstruction The anti-vomiting effect was comparable to what has been seen in patients with severe diabetic gastroparesis, a much more common condition for which GES is better established.
GES does not restore normal gut motility or address the broader problems of CIPO, but for the subset of patients whose quality of life is most undermined by relentless nausea and vomiting, it can be a meaningful intervention. Like much of CIPO treatment, it is about reducing the burden of specific symptoms rather than curing the underlying disease.